Pfizer Inc.

Why would the unvaccinated reject a COVID-19 vaccine, but accept a new antiviral pill?

Justin Trudeau says first shipment of COVID-19 antiviral pill on its way across Canada

Quebec, Ontario officials express cautious COVID optimism, others brace for the worst

Health Canada approves Pfizer’s COVID-19 antiviral pill Paxlovid

Coronavirus Update: Health Canada approves Pfizer’s antiviral COVID-19 drug Paxlovid

Evening Update: Health Canada approves Pfizer’s antiviral COVID-19 drug

Unilever shares fall after company signals pursuit of GSK’s consumer health care business

Health Canada says decision on Pfizer antiviral drug Paxlovid seven to 10 days away

Canadian company behind key COVID-19 vaccine tech inks big development deal with Pfizer

Canada has contracts for up to 100 million Pfizer, Moderna COVID-19 doses in 2022

Pfizer CEO says Omicron-targeted vaccine is most likely outcome

Pfizer expects updated COVID-19 vaccine data for kids under 5 by April

U.S. CDC advisory panel in favour of Pfizer vaccine booster for ages 12 to 15

Gordon Pape: These two stocks have the potential to outperform in 2022

U.S. FDA authorizes Pfizer’s COVID-19 booster shot for 12- to 15-year-olds

Britain approves Pfizer’s antiviral COVID-19 pill

Moderna will drive majority of Canada’s COVID-19 booster campaign

New COVID-19 treatment pills should be taken as soon as possible after symptoms appear

Antiviral pill for COVID-19 unlikely to be approved by Health Canada before new year

U.S. authorizes Paxlovid, Pfizer’s COVID-19 antiviral pill, for at-home use